Senores Pharmaceuticals Ltd Quarterly Results

Gross Sales

153.36

130.3

104.87

103.02

98.26

Excise Duty

0

0

0

0

0

Net Sales

153.36

130.3

104.87

103.02

98.26

Other Operating Income

8.4

7.69

9.34

0

2.37

Other Income

5.41

3.36

11.77

5.16

1.86

Total Income

167.17

141.35

125.98

108.18

102.49

Total Expenditure

112.25

103.83

94.77

77.33

77.36

PBIDT

54.92

37.52

31.21

30.85

25.13

Interest

6.19

5.04

5.3

6.16

5.27

PBDT

48.73

32.48

25.91

24.69

19.86

Depreciation

8.09

5.99

5.23

4.2

3.89

Minority Interest Before NP

0

0

0

0

0

Tax

11.36

4.91

6.73

6.1

1.41

Deferred Tax

-0.84

0.4

-4.02

-2.04

1.49

Reported Profit After Tax

30.12

21.18

17.97

16.43

13.07

Minority Interest After NP

-2.26

1.45

0.14

-0.75

0.23

Net Profit after Minority Interest

32.38

19.73

17.83

17.18

12.84

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

32.38

19.73

17.83

17.18

12.84

EPS (Unit Curr.)

6.54

4.6

3.81

5.04

3.92

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

46.05

46.05

46.05

46.05

46.05

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

35.81

28.79

29.76

29.94

25.57

PBDTM(%)

31.77

24.92

24.7

23.96

20.21

PATM(%)

19.64

16.25

17.13

15.94

13.3